Noninvasive drug delivery.
Advances in biopharmaceutical technology have spawned new drug delivery devices and mechanisms. Noninvasive methods, including iontophoresis and transmucosal drug delivery, have improved treatment of certain patient population. Their use is discussed in the following paper.
Zimmer
R
R
Department of Anesthesiology, University of Utah Health Sciences Center, 50 North Medical Drive, Salt Lake City, UT 84132, USA.
Ashburn
M A
MA
D000278:Administration, Buccal; D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000286:Administration, Sublingual; D000700:Analgesics / Q000008:administration & dosage*; D000701:Analgesics, Opioid / Q000008:administration & dosage; D019162:Anesthetics, Combined / Q000008:administration & dosage; D000779:Anesthetics, Local / Q000008:administration & dosage; D002047:Buprenorphine / Q000008:administration & dosage; D002077:Butorphanol / Q000008:administration & dosage; D016503:Drug Delivery Systems / Q000295:instrumentation / Q000379:methods; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007478:Iontophoresis; D008012:Lidocaine / Q000008:administration & dosage; D000077442:Lidocaine, Prilocaine Drug Combination; D009020:Morphine / Q000008:administration & dosage; D011318:Prilocaine / Q000008:administration & dosage
D000700:Analgesics; D000701:Analgesics, Opioid; D019162:Anesthetics, Combined; D000779:Anesthetics, Local; D000077442:Lidocaine, Prilocaine Drug Combination; D011318:Prilocaine; D002047:Buprenorphine; D009020:Morphine; D008012:Lidocaine; D002077:Butorphanol; D005283:Fentanyl